NASDAQ:VRTX
Vertex Pharmaceuticals Incorporated
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Ambrose Kristen SVP & Chief Accounting Officer Common Stock | 2024-04-03 | -465 −5.84% |
Sachdev Amit EVP Chief Patient & Ext Af Off Common Stock | 2024-02-27 | -5.47K −9.00% |
Wagner Charles F Jr EVP & Chief Financial Officer Common Stock | 2024-02-27 | -3.31K −5.82% |
Kewalramani Reshma CEO & President Common Stock | 2024-02-27 | -9.39K −6.43% |
Altshuler David EVP, Global Research and CSO Common Stock | 2024-02-27 | -8.21K −24.13% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Leiden Jeffrey M CEO & President Common Stock | 2019-02-08 | 113.76K 91.10% |
Leiden Jeffrey M CEO & President Common Stock | 2019-02-13 | -111.43K −46.70% |
Leiden Jeffrey M CEO & President Common Stock | 2020-02-07 | 110.47K 103.88% |
Leiden Jeffrey M Executive Chairman Common Stock | 2021-02-05 | 75.29K 3,257.85% |
Leiden Jeffrey M Executive Chairman Common Stock | 2022-07-27 | -71.74K −96.73% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-04-03 | 2024-04-01 | Ambrose Kristen | SVP & Chief Accounting Officer | 7.74K | 225 | F | Common Stock | -94.07K |
2024-04-03 | 2024-04-02 | Ambrose Kristen | SVP & Chief Accounting Officer | 7.50K | 240 | S | Common Stock | -100.56K |
2024-02-27 | 2024-02-26 | Arbuckle Stuart A | EVP, COO | 49.69K | 5.03K | S | Common Stock | -2.14M |
2024-02-27 | 2024-02-26 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 15.97K | 883 | S | Common Stock | -375.89K |
2024-02-27 | 2024-02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 55.80K | 354 | S | Common Stock | -150.70K |
2024-02-27 | 2024-02-23 | Altshuler David | EVP, Global Research and CSO | 30.05K | 3.97K | F | Common Stock | -1.71M |
2024-02-27 | 2024-02-26 | Altshuler David | EVP, Global Research and CSO | 25.81K | 4.24K | S | Common Stock | -1.80M |
2024-02-27 | 2024-02-23 | Arbuckle Stuart A | EVP, COO | 54.73K | 4.71K | F | Common Stock | -2.04M |
2024-02-27 | 2024-02-23 | Kewalramani Reshma | CEO & President | 136.51K | 9.39K | F | Common Stock | -4.05M |
2024-02-27 | 2024-02-23 | Bozic Carmen | EVP and CMO | 36.94K | 3.31K | F | Common Stock | -1.43M |
2024-02-27 | 2024-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | 7.96K | 883 | S | Common Stock | -375.89K |
2024-02-27 | 2024-02-23 | Ambrose Kristen | SVP & Chief Accounting Officer | 8.85K | 828 | F | Common Stock | -357.52K |
2024-02-27 | 2024-02-23 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 16.86K | 1.65K | F | Common Stock | -714.18K |
2024-02-27 | 2024-02-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 56.16K | 3.31K | F | Common Stock | -1.43M |
2024-02-27 | 2024-02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 58.33K | 2.47K | F | Common Stock | -1.07M |
2024-02-27 | 2024-02-23 | Wagner Charles F Jr | EVP & Chief Financial Officer | 53.58K | 3.31K | F | Common Stock | -1.43M |
2024-02-27 | 2024-02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 55.33K | 3.00K | S | Common Stock | -1.28M |
2024-02-23 | 2024-02-21 | Altshuler David | EVP, Global Research and CSO | 34.02K | 3.00K | S | Common Stock | -1.27M |
2024-02-23 | 2024-02-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 59.47K | 360 | S | Common Stock | -151.84K |
2024-02-23 | 2024-02-21 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 60.80K | 3.19K | S | Common Stock | -1.35M |
2024-02-23 | 2024-02-21 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 18.51K | 1.20K | S | Common Stock | -506.55K |
2024-02-23 | 2024-02-21 | Arbuckle Stuart A | EVP, COO | 59.44K | 3.60K | S | Common Stock | -1.52M |
2024-02-21 | 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 60.31K | 3.37K | F | Common Stock | -1.42M |
2024-02-21 | 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 63.99K | 4.25K | S | Common Stock | -1.79M |
2024-02-21 | 2024-02-16 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 63.68K | 4.50K | F | Common Stock | -1.91M |
2024-02-21 | 2024-02-16 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 21.64K | 1.50K | F | Common Stock | -636.44K |
2024-02-21 | 2024-02-20 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 20.51K | 1.13K | F | Common Stock | -473.15K |
2024-02-21 | 2024-02-20 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 19.71K | 801 | S | Common Stock | -337.05K |
2024-02-21 | 2024-02-16 | Arbuckle Stuart A | EVP, COO | 71.22K | 4.50K | F | Common Stock | -1.91M |
2024-02-21 | 2024-02-16 | Bozic Carmen | EVP and CMO | 43.06K | 3.75K | F | Common Stock | -1.59M |
2024-02-21 | 2024-02-20 | Arbuckle Stuart A | EVP, COO | 67.85K | 3.37K | F | Common Stock | -1.42M |
2024-02-21 | 2024-02-16 | Altshuler David | EVP, Global Research and CSO | 43.84K | 3.75K | F | Common Stock | -1.59M |
2024-02-21 | 2024-02-20 | Wagner Charles F Jr | EVP & Chief Financial Officer | 56.89K | 2.81K | F | Common Stock | -1.18M |
2024-02-21 | 2024-02-16 | Wagner Charles F Jr | EVP & Chief Financial Officer | 59.70K | 3.75K | F | Common Stock | -1.59M |
2024-02-21 | 2024-02-20 | Leiden Jeffrey M | Executive Chairman | 13.78K | 4.12K | F | Common Stock | -1.73M |
2024-02-21 | 2024-02-20 | Arbuckle Stuart A | EVP, COO | 63.04K | 4.80K | S | Common Stock | -2.02M |
2024-02-21 | 2024-02-20 | Bozic Carmen | EVP and CMO | 40.25K | 2.81K | F | Common Stock | -1.18M |
2024-02-21 | 2024-02-20 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 68.24K | 2.62K | F | Common Stock | -1.10M |
2024-02-21 | 2024-02-20 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 59.83K | 480 | S | Common Stock | -201.98K |
2024-02-21 | 2024-02-20 | Altshuler David | EVP, Global Research and CSO | 37.02K | 4.00K | S | Common Stock | -1.68M |
2024-02-21 | 2024-02-20 | Kewalramani Reshma | CEO & President | 145.89K | 7.02K | F | Common Stock | -2.95M |
2024-02-21 | 2024-02-16 | Kewalramani Reshma | CEO & President | 152.91K | 9.36K | F | Common Stock | -3.97M |
2024-02-21 | 2024-02-16 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 70.87K | 3.50K | F | Common Stock | -1.48M |
2024-02-21 | 2024-02-20 | Altshuler David | EVP, Global Research and CSO | 41.03K | 2.81K | F | Common Stock | -1.18M |
2024-02-16 | 2024-02-15 | Leiden Jeffrey M | Executive Chairman | 17.90K | 4.66K | S | Common Stock | -1.95M |
2024-02-16 | 2024-02-14 | Leiden Jeffrey M | Executive Chairman | 22.55K | 4.36K | S | Common Stock | -1.83M |
2024-02-13 | 2024-02-12 | Biller Jonathan | EVP and Chief Legal Officer | 18.28K | 1.74K | S | Common Stock | -727.82K |
2024-02-13 | 2024-02-09 | Biller Jonathan | EVP and Chief Legal Officer | 20.02K | 1.59K | F | Common Stock | -671.31K |
2024-02-13 | 2024-02-09 | Bozic Carmen | EVP and CMO | 46.81K | 2.10K | F | Common Stock | -887.75K |
2024-02-13 | 2024-02-09 | Kewalramani Reshma | CEO & President | 162.27K | 8.26K | F | Common Stock | -3.49M |
2024-02-13 | 2024-02-09 | Arbuckle Stuart A | EVP, COO | 80.01K | 3.18K | F | Common Stock | -1.34M |
2024-02-13 | 2024-02-09 | Wagner Charles F Jr | EVP & Chief Financial Officer | 63.45K | 2.61K | F | Common Stock | -1.10M |
2024-02-13 | 2024-02-09 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 24.05K | 832 | F | Common Stock | -351.72K |
2024-02-13 | 2024-02-12 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 23.14K | 913 | S | Common Stock | -383.68K |
2024-02-13 | 2024-02-12 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 74.36K | 3.22K | S | Common Stock | -1.35M |
2024-02-13 | 2024-02-09 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 68.49K | 2.10K | F | Common Stock | -887.75K |
2024-02-13 | 2024-02-12 | Ambrose Kristen | SVP & Chief Accounting Officer | 9.68K | 1.37K | S | Common Stock | -577.41K |
2024-02-13 | 2024-02-09 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 77.59K | 2.02K | F | Common Stock | -854.78K |
2024-02-13 | 2024-02-12 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 68.18K | 314 | S | Common Stock | -131.96K |
2024-02-13 | 2024-02-09 | Altshuler David | EVP, Global Research and CSO | 50.73K | 2.10K | F | Common Stock | -887.33K |
2024-02-13 | 2024-02-12 | Altshuler David | EVP, Global Research and CSO | 47.59K | 3.15K | S | Common Stock | -1.32M |
2024-02-13 | 2024-02-09 | Ambrose Kristen | SVP & Chief Accounting Officer | 11.05K | 591 | F | Common Stock | -249.84K |
2024-02-13 | 2024-02-12 | Arbuckle Stuart A | EVP, COO | 75.72K | 4.29K | S | Common Stock | -1.80M |
2024-02-12 | 2024-02-09 | Leiden Jeffrey M | Executive Chairman | 30.30K | 8.05K | F | Common Stock | -3.40M |
2024-02-12 | 2024-02-08 | Leiden Jeffrey M | Executive Chairman | 38.35K | 2.70K | F | Common Stock | -1.14M |
2024-02-08 | 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 55.61K | 6.98K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Leiden Jeffrey M | Executive Chairman | 12.89K | 10.46K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Leiden Jeffrey M | Executive Chairman | 33.34K | 20.45K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Arbuckle Stuart A | EVP, COO | 63.53K | 6.98K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Arbuckle Stuart A | EVP, COO | 83.19K | 8.45K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Arbuckle Stuart A | EVP, COO | 74.74K | 11.21K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Leiden Jeffrey M | Executive Chairman | 41.05K | 7.71K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Ambrose Kristen | SVP & Chief Accounting Officer | 9.79K | 2.95K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 64.63K | 5.81K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 72.49K | 7.87K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Altshuler David | EVP, Global Research and CSO | 45.72K | 7.87K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Sachdev Amit | EVP Chief Patient & Ext Af Off | 79.61K | 7.11K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Kewalramani Reshma | CEO & President | 170.53K | 20.33K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Ambrose Kristen | SVP & Chief Accounting Officer | 11.64K | 1.85K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Bozic Carmen | EVP and CMO | 42.98K | 7.87K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Biller Jonathan | EVP and Chief Legal Officer | 16.86K | 6.29K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 16.20K | 2.33K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 24.88K | 4.74K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Wagner Charles F Jr | EVP & Chief Financial Officer | 66.06K | 7.11K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Wagner Charles F Jr | EVP & Chief Financial Officer | 58.95K | 9.44K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Wagner Charles F Jr | EVP & Chief Financial Officer | 49.51K | 5.81K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Kewalramani Reshma | CEO & President | 123.23K | 14.52K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 70.59K | 7.11K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Biller Jonathan | EVP and Chief Legal Officer | 21.61K | 4.74K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Bozic Carmen | EVP and CMO | 35.12K | 5.81K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Kewalramani Reshma | CEO & President | 150.20K | 26.97K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Altshuler David | EVP, Global Research and CSO | 37.85K | 5.81K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 63.48K | 7.87K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Altshuler David | EVP, Global Research and CSO | 52.83K | 7.11K | A | Common Stock | 0 |
2024-02-08 | 2024-02-07 | Bozic Carmen | EVP and CMO | 48.91K | 5.93K | A | Common Stock | 0 |
2024-02-08 | 2024-02-06 | Atkinson Edward Morrow Iii | EVP, Chief Technical Ops. Off. | 20.14K | 3.93K | A | Common Stock | 0 |
2024-01-10 | 2024-01-08 | Leiden Jeffrey M | Executive Chairman | 2.42K | 6.65K | S | Common Stock | -2.79M |
2024-01-04 | 2024-01-02 | Wagner Charles F Jr | EVP & Chief Financial Officer | 43.69K | 3K | S | Common Stock | -1.22M |
2023-12-19 | 2023-12-15 | Kewalramani Reshma | CEO & President | 125.85K | 14.08K | M | Common Stock | 2.64M |
2023-12-19 | 2023-12-15 | Kewalramani Reshma | CEO & President | 111.77K | 3.06K | M | Common Stock | 475.73K |